Specifically, elevated ACACA expression pattern was observed in hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), pancreatic ductal adenocarcinoma (PDAC), prostate adenocarcinoma (PAAD), head and neck squamous cell carcinoma (HNSC), non-small cell lung cancer (NSCLC), esophageal carcinoma (ESCA), and cholangiocarcinoma (CHOL). This evidence concerns the gene ACACA and gastric adenocarcinoma.